Latest

Hengrui Medicine's 2025 revenue reached 31.629 billion yuan, up 13% year-on-year, with innovative drug income hitting 16.342 billion yuan | Earnings report highlights

Hengrui Medicine's 2025 revenue reached 31.629 billion yuan, up 13% year-on-year, with innovative drug income hitting 16.342 billion yuan | Earnings report highlights

March 25, domestic innovative pharma leader Hengrui Medicine disclosed its 2025 annual results report, with revenue and profit achieving double-digit growth and stellar performance in its core innovation business. The annual report shows the company achieved total revenue of RMB 31.629 billion for the year, up 13.02% year-on-year;
Admin